Healthcare provider profile · identity verified

Shanthi Rajaratnam, M.D.

Family Practice · HAMILTON, OH · NPI 1083613129

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	140
Amlodipine Besylate	Amlodipine Besylate	341	93
Levothyroxine Sodium	Levothyroxine Sodium	318	89
Lisinopril	Lisinopril	310	96
Gabapentin	Gabapentin	200	51
Omeprazole	Omeprazole	200	51
Trazodone Hcl	Trazodone Hcl	197	55
Losartan Potassium	Losartan Potassium	189	50
Escitalopram Oxalate	Escitalopram Oxalate	188	48
Metformin Hcl	Metformin Hcl	175	52
Metoprolol Succinate	Metoprolol Succinate	158	44
Simvastatin	Simvastatin	144	38
Albuterol Sulfate Hfa	Albuterol Sulfate	131	45
Jardiance	Empagliflozin	122	25
Duloxetine Hcl	Duloxetine Hcl	120	36
Famotidine	Famotidine	114	43
Metformin Hcl Er	Metformin Hcl	112	30
Furosemide	Furosemide	109	40
Tramadol Hcl	Tramadol Hcl	103	21
Montelukast Sodium	Montelukast Sodium	98	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	29
Pantoprazole Sodium	Pantoprazole Sodium	96	37
Metoprolol Tartrate	Metoprolol Tartrate	92	26
Ozempic	Semaglutide	92	19
Hydrochlorothiazide	Hydrochlorothiazide	88	27
Tamsulosin Hcl	Tamsulosin Hcl	88	28
Fluticasone Propionate	Fluticasone Propionate	86	39
Pravastatin Sodium	Pravastatin Sodium	86	22
Ezetimibe	Ezetimibe	75	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	17
Trulicity	Dulaglutide	75	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	12
Sertraline Hcl	Sertraline Hcl	73	19
Rosuvastatin Calcium	Rosuvastatin Calcium	64	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	19
Januvia	Sitagliptin Phosphate	59	11
Hydroxyzine Hcl	Hydroxyzine Hcl	56	23
Allopurinol	Allopurinol	55	17
Hydroxyzine Pamoate	Hydroxyzine Pamoate	54	suppressed
Donepezil Hcl	Donepezil Hcl	52	15
Ropinirole Hcl	Ropinirole Hcl	49	14
Synthroid	Levothyroxine Sodium	49	12
Buspirone Hcl	Buspirone Hcl	48	13
Citalopram Hbr	Citalopram Hydrobromide	48	15
Olanzapine	Olanzapine	48	12
Diclofenac Sodium	Diclofenac Sodium	42	19
Glimepiride	Glimepiride	42	15
Oxybutynin Chloride Er	Oxybutynin Chloride	42	12
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	41	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	41	13
Atenolol	Atenolol	40	12
Celecoxib	Celecoxib	40	suppressed
Meclizine Hcl	Meclizine Hcl	40	22
Prednisone	Prednisone	40	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Topiramate	Topiramate	39	suppressed
Methocarbamol	Methocarbamol	38	16
Methylprednisolone	Methylprednisolone	38	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Meloxicam	Meloxicam	36	11
Doxycycline Hyclate	Doxycycline Hyclate	35	31
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	18
Alendronate Sodium	Alendronate Sodium	32	11
Terazosin Hcl	Terazosin Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Spironolactone	Spironolactone	31	11
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Verapamil Er	Verapamil Hcl	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Bupropion Xl	Bupropion Hcl	29	11
Carvedilol	Carvedilol	29	suppressed
Fenofibrate	Fenofibrate,micronized	28	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Metronidazole	Metronidazole	22	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Buprenorphine	Buprenorphine	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Risperidone	Risperidone	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Benazepril Hcl	Benazepril Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Fluconazole	Fluconazole	18	15
Valacyclovir	Valacyclovir Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Colesevelam Hcl	Colesevelam Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Valsartan	Valsartan	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Glipizide	Glipizide	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Nystatin	Nystatin	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error